References
- Eapen L, Stewart D, Collins J. Effective bladder sparing therapy with intra-arterial cisplatin and radiotherapy for localized bladder cancer. J Urol 2004:172 (4): 1276–80
- Mokarin A, Uetani M, Hayashi N, et al. Combined intra-arterial chemotherapy and radiotherapy in treatment of bladder carcinoma. Cancer 1997: 80 (9): 1776–85
- Mokarin A, Uetani M, Sakamoto 1, et al. Transarterial in-fusion of cisplatin and doxorubicin in bladder cancer. Acta Oncol 1997: 36 (2): 175–81
- Hassan JM, Cookson MS, Smith JA. Pattern of initial tran-sitional cell recurrence in patients after cystectomy. J Urol 2006:175 (6): 2054–7
- Stein JP, Lieskowsky G, Cote R, et al. Radical cystectomy in treatment of invasive bladder cancer: long-term results in 1054 patients. J Clin Oncol 2001: 19 (3): 666–75
- Therasse P, Arbuck SG, Eisenhauer EA, et al. New guide-lines to evaluate response to treatment in solid tumors. J Natl Cancer Inst 2000:92 (3): 205–16
- Zhou FJ, Liu ZW, Yu SL, et al. Modified total cystectomy and neobladder: experience with 96 cases of invasive bladder cancer. Chin J Urol 2006: 27 (8): 549–51
- Madersbacher S, Hochreiter W, Burkhard F, et al. Radical cystectomy for bladder cancer today—a homogeneous series without neoadjuvant therapy. J Clin Oncol 2003:21 (4): 690–6
- von der Maase H, Hansen SW, Roberts JT, et al. Gemc-itabine and cisplatin versus methotrexate, vinblastine, doxoru-bicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study. J Clin Oncol 2000:18 (17): 3068–77
- von der Maase H, Sengelov L, Roberts JT, et al. Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer. J Clin Oncol 2005:23 (21): 4602–8
- Bajorin DF, Dodd PM, Mazumdar M, et al. Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy.J Clin Oncol 1999:17 (10): 3173–81
- Hoshi S, Mao H, Takahashi T, et al. Internal iliac arterial infusion chemotherapy for rabbit invasive bladder cancer. Int J Urol 1997: 4 (5): 493–9
- Daniels JR, Sternlicht M, Daniels AM. Collagen chemoembolization: pharmacokinetics and tissue tolerance of cis-diamminedichloroplatinum(II) in porcine liver and rabbit kid-ney.Cancer Res. 1988:48 (9): 2446–50
- Harima K, Harima Y, Hasegawa T, Tanaka Y. Tran-scatheter arterial embolization as a method of cisplatin-retention enhancement on the VX2 tumor uterus transplants. Cardiovasc Intervent Radiol. 1995: 18 (1): 30–4
- Stewart DJ, Benjamin RS, Zimmerman S, et al. Clinical pharmacology of intraarterial cis-diamminedichloroplatinum(II). cancer Res 1983: 43 (February):917–20
- Mantadaks E, Panagiotidis C, Delakas D, et al. Sympto-matic relief of patients with advanced bladder carcinoma after re-gional intra-arterial chemotherapy. Anticancer Research, 2003:23 (60): 5143–7
- Stewart DJ, Eapen L, Hirte WE, et al. Intra-arterial cis-platin for bladder cancer. J Urol 1987:138 (2): 302–5
- Tsukamoto S, Ishikawa S, Tsutsumi M, et al. An organ sparing treatment using combined intra-arterial chemotherapy and radiotherapy for muscle-invasive bladder carcinoma. Scand J Urol Nephrol 2002: 36 (3): 339–43
- Siefker-radtke AO, Walsh GL, Pisters LL, et al. Is there a role for surgery in the management of metastatic urothelial can-cer? The M.D. Anderson experience. J Urol 2004:171 (1): 145–8
- Herr HW, Donat SM, Bajorin DF. Post-chemotherapy surgery in patients with unresectable or regionally metastatic blad-der cancer. J Urol 2001:165 (3): 81–4
- Sweeney P, Millikan R, Donat M, et al. Is there a thera-peutic role for post-chemotherapy retroperitoneal lymph node dissection in metastatic transitional cell carcinoma of the blad-der? J Urol 2003: 169 (6): 2113–7